Showing results (281-290 of 403) with videos related to
Sort By:
Pageof 41
Acta Tropica|December 27, 2018
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis speciesGrasiele S V Tavares, Débora V C Mendonça, Daniela P Lage, et al.Experimental Parasitology|March 1, 2019
Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasisTauane G Soyer, Débora V C Mendonça, Grasiele S V Tavares, et al.Pathogens (Basel, Switzerland)|February 25, 2023
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensisTauane G Soyer, Fernanda F Ramos, Isabela A G Pereira, et al.The Journal of Urology|June 18, 2011
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional studyVipul R Patel, Rafael F Coelho, Bernardo Rocco, et al.Cellular Immunology|October 6, 2018
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individualsMariana P Lima, Lourena E Costa, Daniela P Lage, et al.Plants (Basel, Switzerland)|June 10, 2022
Enrichment of Grapes with Zinc-Efficiency of Foliar Fertilization with ZnSO4 and ZnO and Implications on WinemakingDiana Daccak, Fernando C Lidon, Cláudia Campos Pessoa, et al.Parasitology International|October 20, 2018
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infectionGrasiele S V Tavares, Débora V C Mendonça, Carolina K Miyazaki, et al.Experimental Parasitology|May 29, 2023
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasisCamila S Freitas, Samira S Santiago, Daniela P Lage, et al.Biology|June 28, 2023
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral LeishmaniasisDanniele L Vale, Camila S Freitas, Vívian T Martins, et al.Immunobiology|October 28, 2017
Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasisÁquila S B Portela, Lourena E Costa, Beatriz C S Salles, et al.Pageof 41